Literature DB >> 29570241

Acute cardiac events in severe community-acquired pneumonia: A multicenter study.

Aykut Cilli1, Ozlem Cakin1, Emine Aksoy2, Feyza Kargin2, Nalan Adiguzel2, Zuhal Karakurt2, Begum Ergan3, Seda Mersin3, Selen Bozkurt1, Fatma Ciftci4, Melike Cengiz1.   

Abstract

INTRODUCTION: An increased risk of cardiovascular complications has been defined in community-acquired pneumonia (CAP), but limited data is available for patients with severe CAP.
OBJECTIVE: The aim of the present study was to define the prevalence, characteristics, risk factors and impact on mortality of acute cardiac events in patients with severe CAP during short and long term.
METHOD: This investigation was a multicenter, retrospective cohort sudy of patients with severe CAP. Cardiac events were defined as cardiac arrhytmia, congestive heart failure and myocardial infarction. A logistic regression analysis was performed to identify predictors for acute cardiac events and mortality.
RESULTS: Of 373 patients (mean age 68 ± 16, 61.4% male), 56 (15%) developed a cardiac event (43 arrhythmia, 11 congestive heart failure and 2 myocardial infarction). Patients who developed an acute cardiac event were older, had more severe disease, pleural effusion, hypoalbuminemia, hyponatremia and more acidosis. Also, beta-blocker and diuretic use were more significant in these patients. In-hospital mortality was significantly higher in patients who developed cardiac events (29.6% vs 11%, P < .001). According to the logistic regression analysis, haloperidol, vasopressor or diuretic use, hypoalbuminemia and age were the predictors for acute cardiac events. Acute cardiac events were significantly associated with in-hospital mortality (OR 2.1; 95%CI 1.03-4.61, P = .04), but not associated with 90-day mortality.
CONCLUSION: Our findings demonstrated that acute cardiac events are seen in a substantial proportion of patients with severe CAP and their occurence significantly associated with in-hospital mortality.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  arrhytmia; cardiac event; community-acquired pneumonia; congestive heart failure; myocardial infarction

Mesh:

Substances:

Year:  2018        PMID: 29570241     DOI: 10.1111/crj.12791

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  6 in total

1.  Age, Pulse, Urea and Albumin (APUA) Model: A Tool for Predicting in-Hospital Mortality of Community-Acquired Pneumonia Adapted for Patients with Type 2 Diabetes.

Authors:  Chun-Ming Ma; Ning Wang; Quan-Wei Su; Ying Yan; Fu-Zai Yin
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-09       Impact factor: 3.168

Review 2.  Cardiovascular Events After Community-Acquired Pneumonia: A Global Perspective with Systematic Review and Meta-Analysis of Observational Studies.

Authors:  António Tralhão; Pedro Póvoa
Journal:  J Clin Med       Date:  2020-02-03       Impact factor: 4.241

Review 3.  Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications.

Authors:  Lulu Ma; Kaicheng Song; Yuguang Huang
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-04-30       Impact factor: 2.628

4.  Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent.

Authors:  Hector F Africano; Cristian C Serrano-Mayorga; Paula C Ramirez-Valbuena; Ingrid G Bustos; Alirio Bastidas; Hernan A Vargas; Sandra Gómez; Alejandro Rodriguez; Carlos J Orihuela; Luis F Reyes
Journal:  Clin Infect Dis       Date:  2021-06-01       Impact factor: 9.079

Review 5.  Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019.

Authors:  Vineeta Tanwar; Jeremy M Adelstein; Loren E Wold
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 10.787

Review 6.  Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.